Cargando…
Identification of new prognostic biomarkers for Stage III metastatic melanoma patients
Accurately predicting disease outcome among patients bearing Stage III metastatic melanoma is complex. However, current advances in personalized medicine call for ever more precise prognostic assessments, as these have a significant impact not only on the design and analysis of clinical trials, but...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820811/ https://www.ncbi.nlm.nih.gov/pubmed/24228228 http://dx.doi.org/10.4161/onci.25564 |